BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 29567771)

  • 41. BCL2 mutation spectrum in B-cell non-Hodgkin lymphomas and patterns associated with evolution of follicular lymphoma.
    Burkhard R; Bhagat G; Cogliatti SB; Rossi D; Gaidano G; Pasqualucci L; Novak U
    Hematol Oncol; 2015 Mar; 33(1):23-30. PubMed ID: 24496723
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Immunophenotyping and molecular genetic analysis of diffuse large B-cell lymphoma].
    Han YS; Xue YQ; Yang HY; Zhang J; Pan JL
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2013 Apr; 30(2):143-7. PubMed ID: 23568722
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Double-hit B-cell lymphomas with BCL6 and MYC translocations are aggressive, frequently extranodal lymphomas distinct from BCL2 double-hit B-cell lymphomas.
    Pillai RK; Sathanoori M; Van Oss SB; Swerdlow SH
    Am J Surg Pathol; 2013 Mar; 37(3):323-32. PubMed ID: 23348205
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinicopathological characteristics and genomic profile of primary sinonasal tract diffuse large B cell lymphoma (DLBCL) reveals gain at 1q31 and RGS1 encoding protein; high RGS1 immunohistochemical expression associates with poor overall survival in DLBCL not otherwise specified (NOS).
    Carreras J; Kikuti YY; Beà S; Miyaoka M; Hiraiwa S; Ikoma H; Nagao R; Tomita S; Martin-Garcia D; Salaverria I; Sato A; Ichiki A; Roncador G; Garcia JF; Ando K; Campo E; Nakamura N
    Histopathology; 2017 Mar; 70(4):595-621. PubMed ID: 27775850
    [TBL] [Abstract][Full Text] [Related]  

  • 45. BCL2 translocation defines a unique tumor subset within the germinal center B-cell-like diffuse large B-cell lymphoma.
    Iqbal J; Sanger WG; Horsman DE; Rosenwald A; Pickering DL; Dave B; Dave S; Xiao L; Cao K; Zhu Q; Sherman S; Hans CP; Weisenburger DD; Greiner TC; Gascoyne RD; Ott G; Müller-Hermelink HK; Delabie J; Braziel RM; Jaffe ES; Campo E; Lynch JC; Connors JM; Vose JM; Armitage JO; Grogan TM; Staudt LM; Chan WC
    Am J Pathol; 2004 Jul; 165(1):159-66. PubMed ID: 15215171
    [TBL] [Abstract][Full Text] [Related]  

  • 46. MicroRNA signatures in subtypes of follicular lymphoma.
    Gebauer N; Gollub W; Stassek B; Bernard V; Rades D; Feller AC; Thorns C
    Anticancer Res; 2014 May; 34(5):2105-11. PubMed ID: 24778012
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Lymphoblastic lymphoma with a triple-hit profile: a rare but distinct and relevant entity.
    Hiemcke-Jiwa LS; Leguit RJ; van der Veken LT; Buijs A; Leeuwis JW; de Boer M; Jiwa NM; Bloem AC; Petersen EJ; de Weger RA; Huibers MMH
    Hum Pathol; 2017 May; 63():171-176. PubMed ID: 27867103
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prognostic implications of histologic grade and intensity of Bcl-2 expression in follicular lymphomas undergoing rituximab-containing therapy.
    Maeshima AM; Taniguchi H; Nomoto J; Miyamoto K; Fukuhara S; Munakata W; Maruyama D; Kim SW; Watanabe T; Kobayashi Y; Tobinai K; Tsuda H
    Hum Pathol; 2013 Nov; 44(11):2529-35. PubMed ID: 23916290
    [TBL] [Abstract][Full Text] [Related]  

  • 49. CD10 down expression in follicular lymphoma correlates with gastrointestinal lesion involving the stomach and large intestine.
    Ohnishi N; Takata K; Miyata-Takata T; Sato Y; Tari A; Gion Y; Noujima-Harada M; Taniguchi K; Tabata T; Nagakita K; Omote S; Takahata H; Iwamuro M; Okada H; Maeda Y; Yanai H; Yoshino T
    Cancer Sci; 2016 Nov; 107(11):1687-1695. PubMed ID: 27513891
    [TBL] [Abstract][Full Text] [Related]  

  • 50. High-grade B-cell lymphoma with MYC and BCL2 rearrangements arising in a composite lymphoma.
    Moore AM; Moshkin O; Swain GJ; Crocker S; LeBrun DP
    Diagn Pathol; 2018 May; 13(1):34. PubMed ID: 29793519
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Different biological risk factors in young poor-prognosis and elderly patients with diffuse large B-cell lymphoma.
    Horn H; Ziepert M; Wartenberg M; Staiger AM; Barth TF; Bernd HW; Feller AC; Klapper W; Stuhlmann-Laeisz C; Hummel M; Stein H; Lenze D; Hartmann S; Hansmann ML; Möller P; Cogliatti S; Pfreundschuh M; Trümper L; Loeffler M; Glass B; Schmitz N; Ott G; Rosenwald A;
    Leukemia; 2015 Jul; 29(7):1564-70. PubMed ID: 25687653
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Methylation changes of SIRT1, KLF4, DAPK1 and SPG20 in B-lymphocytes derived from follicular and diffuse large B-cell lymphoma.
    Frazzi R; Zanetti E; Pistoni M; Tamagnini I; Valli R; Braglia L; Merli F
    Leuk Res; 2017 Jun; 57():89-96. PubMed ID: 28324774
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Lymphoid follicle colonization by Bcl-2(bright+)CD10(+) B-cells ("follicular lymphoma in situ") at nodal and extranodal sites can be a manifestation of follicular homing of lymphoma.
    Lee JC; Hoehn D; Schecter J; Murty VV; Mansukhani MM; Alobeid B; Bhagat G
    Hum Pathol; 2013 Jul; 44(7):1328-40. PubMed ID: 23363648
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Analysis of genomic copy number alterations of malignant lymphomas and its application for diagnosis].
    Tagawa H
    Gan To Kagaku Ryoho; 2007 Jul; 34(7):975-82. PubMed ID: 17637530
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical impact of molecular features in diffuse large B-cell lymphoma and follicular lymphoma.
    Pon JR; Marra MA
    Blood; 2016 Jan; 127(2):181-6. PubMed ID: 26447189
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Diagnostic and prognostic significance of gene expression profiling in lymphomas.
    Leich E; Hartmann EM; Burek C; Ott G; Rosenwald A
    APMIS; 2007 Oct; 115(10):1135-46. PubMed ID: 18042147
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Coexpression of Bcl-6 and CD10 in diffuse large B-cell lymphomas: significance of Bcl-6 expression patterns in identifying germinal center B-cell lymphoma.
    Ree HJ; Yang WI; Kim CW; Huh J; Lee SS; Cho EY; Ko YH; Charney D
    Hum Pathol; 2001 Sep; 32(9):954-62. PubMed ID: 11567225
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pathology of follicular lymphoma.
    Takata K; Miyata-Takata T; Sato Y; Yoshino T
    J Clin Exp Hematop; 2014; 54(1):3-9. PubMed ID: 24942941
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Molecular and immunohistochemical characterization of B-cell lymphoma-2-negative follicular lymphomas.
    Hoeller S; Bihl MP; Zihler D; Cogliatti S; Ponzoni M; Zettl A; Went P; Foerster A; Hirschmann P; Tzankov A; Dirnhofer S
    Hum Pathol; 2012 Mar; 43(3):405-12. PubMed ID: 21855110
    [TBL] [Abstract][Full Text] [Related]  

  • 60. CD10-MUM1+ follicular lymphoma lacks BCL2 gene translocation and shows characteristic biologic and clinical features.
    Karube K; Guo Y; Suzumiya J; Sugita Y; Nomura Y; Yamamoto K; Shimizu K; Yoshida S; Komatani H; Takeshita M; Kikuchi M; Nakamura N; Takasu O; Arakawa F; Tagawa H; Seto M; Ohshima K
    Blood; 2007 Apr; 109(7):3076-9. PubMed ID: 17138820
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.